https://www.sciencedaily.com/news/health_medicine/tuberculosis/ Tuberculosis. Read the latest research news on tuberculosis, including a quick new TB test, new TB treatment options, and the latest news on tuberculosis infections. en-us Sat, 11 Apr 2026 09:57:23 EDT Sat, 11 Apr 2026 09:57:23 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/health_medicine/tuberculosis/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/02/260222092258.htm Scientists at Stanford Medicine have unveiled a bold new kind of “universal” vaccine that could one day protect against everything from COVID-19 and the flu to bacterial pneumonia and even common allergens. Instead of targeting a specific virus or bacterium, the nasal spray vaccine supercharges the lungs’ own immune defenses, keeping them on high alert for months. In mice, it slashed viral levels, prevented severe illness, and even blocked allergic reactions. Mon, 23 Feb 2026 08:45:18 EST https://www.sciencedaily.com/releases/2026/02/260222092258.htm https://www.sciencedaily.com/releases/2026/02/260218031502.htm Deep inside a Romanian ice cave, locked away in a 5,000-year-old layer of ice, scientists have uncovered a bacterium with a startling secret: it’s resistant to many modern antibiotics. Despite predating the antibiotic era, this cold-loving microbe carries more than 100 resistance-related genes and can survive drugs used today to treat serious infections like tuberculosis and UTIs. Sat, 21 Feb 2026 22:38:58 EST https://www.sciencedaily.com/releases/2026/02/260218031502.htm https://www.sciencedaily.com/releases/2026/02/260206020850.htm Scientists in Australia have uncovered a clever new way to fight some of the most dangerous drug-resistant bacteria by targeting a sugar that exists only on bacterial cells. By designing antibodies that recognize this unique sugar, researchers were able to guide the immune system to attack and eliminate deadly infections that normally shrug off antibiotics. Fri, 06 Feb 2026 04:09:04 EST https://www.sciencedaily.com/releases/2026/02/260206020850.htm https://www.sciencedaily.com/releases/2026/01/260121034134.htm Fungal infections are becoming deadlier as drug resistance spreads and treatment options stall. Researchers at McMaster University discovered that a molecule called butyrolactol A can dramatically weaken dangerous fungi, allowing existing antifungal drugs to work again. Instead of killing the fungus directly, the molecule sabotages a vital internal system, leaving the pathogen exposed. The breakthrough could help revive an entire class of antifungal medicines once thought obsolete. Thu, 22 Jan 2026 02:05:14 EST https://www.sciencedaily.com/releases/2026/01/260121034134.htm https://www.sciencedaily.com/releases/2026/01/260120015646.htm Scientists have uncovered new clues about why diabetic foot infections can become so severe and difficult to treat. By analyzing the DNA of E. coli bacteria taken from infected wounds around the world, researchers found an unexpected level of diversity, with many strains carrying genes linked to antibiotic resistance and aggressive disease. Rather than a single dangerous strain, multiple types of E. coli appear able to thrive in diabetic foot ulcers, helping explain why infections can worsen quickly and sometimes lead to amputation. Tue, 20 Jan 2026 02:02:20 EST https://www.sciencedaily.com/releases/2026/01/260120015646.htm https://www.sciencedaily.com/releases/2026/01/260112211455.htm Some antibiotics stop bacteria from growing without actually killing them, allowing infections to return later. Scientists at the University of Basel created a new test that tracks individual bacteria to see which drugs truly eliminate them. When tested on tuberculosis and other serious lung infections, the method revealed big differences in how bacteria tolerate treatment. The findings could lead to more precise therapies and better predictions of treatment success. Mon, 12 Jan 2026 21:33:16 EST https://www.sciencedaily.com/releases/2026/01/260112211455.htm https://www.sciencedaily.com/releases/2025/12/251214100911.htm Scientists are uncovering a new possibility behind long COVID’s stubborn symptoms: hidden infections that awaken or emerge alongside SARS-CoV-2. Evidence is mounting that viruses like Epstein-Barr and even latent tuberculosis may flare up when COVID disrupts the immune system, creating lingering fatigue, brain fog, and other debilitating issues. Sun, 14 Dec 2025 22:36:14 EST https://www.sciencedaily.com/releases/2025/12/251214100911.htm https://www.sciencedaily.com/releases/2025/11/251104094136.htm Researchers have, for the first time, estimated how quickly E. coli bacteria can spread between people — and one strain moves as fast as swine flu. Using genomic data from the UK and Norway, scientists modeled bacterial transmission rates and discovered key differences between strains. Their work offers a new way to monitor and control antibiotic-resistant bacteria in both communities and hospitals. Tue, 04 Nov 2025 23:25:35 EST https://www.sciencedaily.com/releases/2025/11/251104094136.htm https://www.sciencedaily.com/releases/2025/11/251104013033.htm A new compound called CMX410 may change the fight against tuberculosis. It targets a weak point in the bacteria’s defenses, even in drug-resistant forms of the disease. Created using a cutting-edge chemistry method, the drug shows promise for being both powerful and safe. Scientists believe it could lead to shorter, more effective treatments for millions of people. Tue, 04 Nov 2025 09:32:33 EST https://www.sciencedaily.com/releases/2025/11/251104013033.htm https://www.sciencedaily.com/releases/2025/09/250919085235.htm For decades, scientists have puzzled over why smoking makes Crohn’s disease worse but seems to protect people from ulcerative colitis. Now, researchers at RIKEN have discovered that smoking creates metabolites like hydroquinone that allow mouth bacteria—especially Streptococcus mitis—to settle in the gut. These bacteria spark an immune response that reduces inflammation in colitis but worsens Crohn’s. The findings open the door to new therapies using probiotics or targeted compounds that mimic smoking’s protective effects without its deadly risks. Fri, 19 Sep 2025 20:28:11 EDT https://www.sciencedaily.com/releases/2025/09/250919085235.htm https://www.sciencedaily.com/releases/2025/06/250630073438.htm Leprosy’s tale stretches from 5,000-year-old skeletons in Eurasia to a startling 4,000-year-old case in Chile, revealing that the rare strain Mycobacterium lepromatosis haunted the Americas millennia before Europeans arrived. Armed with cutting-edge ancient-DNA sleuthing, scientists have pieced together remarkably well-preserved genomes that challenge the idea of leprosy as purely a colonial import and hint that the disease may have homegrown American roots awaiting confirmation by future finds. Mon, 30 Jun 2025 08:07:04 EDT https://www.sciencedaily.com/releases/2025/06/250630073438.htm https://www.sciencedaily.com/releases/2025/05/250529155423.htm Long considered a disease brought to the Americas by European colonizers, leprosy may actually have a much older history on the American continent. Scientists reveal that a recently identified second species of bacteria responsible for leprosy, Mycobacterium lepromatosis, has been infecting humans in the Americas for at least 1,000 years, several centuries before the Europeans arrived. Thu, 29 May 2025 15:54:23 EDT https://www.sciencedaily.com/releases/2025/05/250529155423.htm https://www.sciencedaily.com/releases/2025/05/250529124854.htm The process of necrosis, a form of cell death, may represent one of the most promising ways to change the course of human aging, disease and even space travel, according to a new study. Thu, 29 May 2025 12:48:54 EDT https://www.sciencedaily.com/releases/2025/05/250529124854.htm https://www.sciencedaily.com/releases/2025/05/250520121152.htm By studying Chikungunya virus, scientists shed light on how immune responses to viral infections may lead to persistent symptoms of autoimmune disease. Tue, 20 May 2025 12:11:52 EDT https://www.sciencedaily.com/releases/2025/05/250520121152.htm https://www.sciencedaily.com/releases/2025/05/250505170649.htm Chemists found a way to identify a complex sugar molecule in the cell walls of Mycobacterium tuberculosis, the world's deadliest pathogen. This labeling could lead to simpler, faster TB tests. Mon, 05 May 2025 17:06:49 EDT https://www.sciencedaily.com/releases/2025/05/250505170649.htm https://www.sciencedaily.com/releases/2025/04/250430142010.htm Researchers have developed a novel rat model that closely replicates the pathological features and physiological changes associated with human chronic obstructive pulmonary disease (COPD)-associated cor pulmonale. This model exhibits key characteristics, including chronic lung inflammation, pulmonary hypertension, and right ventricular hypertrophy. The new study details the potential for the model to unravel the complex interactions between lung and heart pathology and improve patient outcomes. Wed, 30 Apr 2025 14:20:10 EDT https://www.sciencedaily.com/releases/2025/04/250430142010.htm https://www.sciencedaily.com/releases/2025/04/250430141853.htm Results of a large, global clinical trial spanning five continents with over 1,700 patients with bronchiectasis has demonstrated benefits of an investigational, once-a-day pill called brenso catib as a therapy for the chronic lung condition. It may soon become the first-ever FDA-approved treatment for bronchiectasis. Wed, 30 Apr 2025 14:18:53 EDT https://www.sciencedaily.com/releases/2025/04/250430141853.htm https://www.sciencedaily.com/releases/2025/04/250423214339.htm A new strategy for tuberculosis (TB) screening provides a solution to problems with current TB screening, which does not always accurately detect disease. Simultaneously screening for both active and dormant TB infection could save lives, curtail infection rates, and rewrite the story of the continued spread of this disease. Researchers hope that this new approach will inform guidance from global health organizations and key decision-makers on the most effective way to screen for TB. Wed, 23 Apr 2025 21:43:39 EDT https://www.sciencedaily.com/releases/2025/04/250423214339.htm https://www.sciencedaily.com/releases/2025/04/250421163229.htm An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators report. Mon, 21 Apr 2025 16:32:29 EDT https://www.sciencedaily.com/releases/2025/04/250421163229.htm https://www.sciencedaily.com/releases/2025/04/250409154631.htm This handheld device is the first that can detect tuberculosis in saliva, in addition to blood and sputum samples, an important breakthrough for testing children and HIV patients, who struggle to produce sputum. The device was found to deliver rapid, accurate results in under an hour, offering a cost-effective and accessible solution for diagnosing TB in resource-limited areas. Wed, 09 Apr 2025 15:46:31 EDT https://www.sciencedaily.com/releases/2025/04/250409154631.htm https://www.sciencedaily.com/releases/2025/04/250407173027.htm Scientists have developed an artificial intelligence-based method to more accurately detect antibiotic resistance in deadly bacteria such as tuberculosis and staph. The breakthrough could lead to faster and more effective treatments and help mitigate the rise of drug-resistant infections, a growing global health crisis. Mon, 07 Apr 2025 17:30:27 EDT https://www.sciencedaily.com/releases/2025/04/250407173027.htm https://www.sciencedaily.com/releases/2025/04/250404122634.htm The Xpert MTB/Ultra molecular diagnostic test for stool samples, until now recommended only for children, could be established as an additional test for diagnosing tuberculosis in adults living with HIV. Fri, 04 Apr 2025 12:26:34 EDT https://www.sciencedaily.com/releases/2025/04/250404122634.htm https://www.sciencedaily.com/releases/2025/03/250328112544.htm Researchers show that the immune system can recognize and control the latent stage of the parasite Toxoplasma gondii, a finding that can inform the study of latency in other infections of the nervous system. Fri, 28 Mar 2025 11:25:44 EDT https://www.sciencedaily.com/releases/2025/03/250328112544.htm https://www.sciencedaily.com/releases/2025/03/250325114915.htm Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting the expression or function of Piezo2, a receptor that senses mechanical forces in tissues including stress, strain, and stiffness. The new study sheds light on the underlying mechanisms of pulmonary fibrotic diseases and identifies potential new targets and options for therapy to improve patients' outcomes. Tue, 25 Mar 2025 11:49:15 EDT https://www.sciencedaily.com/releases/2025/03/250325114915.htm https://www.sciencedaily.com/releases/2025/03/250321163545.htm New research shows how a specially trained population of immune cells keeps the peace by preventing other immune cells from attacking their own. The study provides a better understanding of immune regulation during infection and could provide a foundation for interventions to prevent or reverse autoimmune diseases. Fri, 21 Mar 2025 16:35:45 EDT https://www.sciencedaily.com/releases/2025/03/250321163545.htm https://www.sciencedaily.com/releases/2025/03/250319143422.htm Campylobacter infections are the most common foodborne illnesses in the U.S., sickening an estimated 1.5 million people each year. A new study examined records of Campylobacter jejuni infections from 10 states, plotting regional, age-related, and drug-resistance trends from 2013 to 2019. The study found that drug-resistant C. jejuni infections were highest in the 20-39 age group and that quinolone-resistant C. jejuni infections increased from 2013-2019. The researchers also identified regional differences in C. jejuni resistance to quinolones and six other classes of antibiotics. Wed, 19 Mar 2025 14:34:22 EDT https://www.sciencedaily.com/releases/2025/03/250319143422.htm https://www.sciencedaily.com/releases/2025/03/250310134150.htm Scientists discovered genes in the tuberculosis bacterium that becomes essential for the pathogen's survival when it's exposed to air through coughing. These genes could be targets for new therapies that simultaneously treat infection and prevent transmission. Mon, 10 Mar 2025 13:41:50 EDT https://www.sciencedaily.com/releases/2025/03/250310134150.htm https://www.sciencedaily.com/releases/2025/03/250303141103.htm Pneumocystis jirovecii pneumonia (PJP) is the most common fungal pneumonia in children. But current diagnostic methods can take days an require an invasive bronchoscopy procedure. Now, a new CRISPR-based test has been developed to diagnose PJP more quickly and less invasively. Mon, 03 Mar 2025 14:11:03 EST https://www.sciencedaily.com/releases/2025/03/250303141103.htm https://www.sciencedaily.com/releases/2025/02/250225132257.htm Working toward more effective tuberculosis (TB) vaccines, researchers have developed two strains of mycobacteria with 'kill switches' that can be triggered to stop the bacteria after they activate an immune response. Tue, 25 Feb 2025 13:22:57 EST https://www.sciencedaily.com/releases/2025/02/250225132257.htm https://www.sciencedaily.com/releases/2025/02/250219225212.htm A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in immune cells that, when blocked, could significantly reduce lung tissue scarring. Wed, 19 Feb 2025 22:52:12 EST https://www.sciencedaily.com/releases/2025/02/250219225212.htm https://www.sciencedaily.com/releases/2025/02/250218145816.htm Researchers are tackling neutrophilic asthma, successfully developing one of the first mouse models of the condition. Tue, 18 Feb 2025 14:58:16 EST https://www.sciencedaily.com/releases/2025/02/250218145816.htm https://www.sciencedaily.com/releases/2025/02/250212151511.htm Researchers have proven that antibiotic-resistant strains of a harmful bacteria thrive in a diabetic infection environment. Wed, 12 Feb 2025 15:15:11 EST https://www.sciencedaily.com/releases/2025/02/250212151511.htm https://www.sciencedaily.com/releases/2025/02/250210133013.htm A new blood test is designed to find mold infections deep inside the body, sparing patients from tissue biopsies. Mon, 10 Feb 2025 13:30:13 EST https://www.sciencedaily.com/releases/2025/02/250210133013.htm https://www.sciencedaily.com/releases/2025/01/250129194552.htm Study finds three new safe and effective drug regimens to fight multidrug-resistant TB. The treatments, which include recently discovered TB drugs, give new options for shorter, personalized treatment and are cleared for use for more people than ever. Wed, 29 Jan 2025 19:45:52 EST https://www.sciencedaily.com/releases/2025/01/250129194552.htm https://www.sciencedaily.com/releases/2025/01/250115125709.htm Sydney researchers have found that Levofloxacin substantially reduces risk of drug-resistant tuberculosis. This discovery offers new hope against a disease that infects more than 400,000 people annually. Wed, 15 Jan 2025 12:57:09 EST https://www.sciencedaily.com/releases/2025/01/250115125709.htm https://www.sciencedaily.com/releases/2025/01/250110121922.htm The in-built in protection mechanisms offer a safer and more effective way to combat the deadliest disease of 2024. Fri, 10 Jan 2025 12:19:22 EST https://www.sciencedaily.com/releases/2025/01/250110121922.htm https://www.sciencedaily.com/releases/2025/01/250106133202.htm Tuberculosis (TB) is the world's biggest infectious disease killer with multidrug-resistant TB (MDR-TB) posing a particular threat to global health. A study shows that resistance to the new MDR-TB treatment regimen recently recommended by the World Health Organization is already spreading between patients. Mon, 06 Jan 2025 13:32:02 EST https://www.sciencedaily.com/releases/2025/01/250106133202.htm https://www.sciencedaily.com/releases/2024/12/241220153505.htm A breakthrough in understanding how a single-cell parasite makes ergosterol (its version of cholesterol) could lead to more effective drugs for human leishmaniasis, a parasitic disease that afflicts about 1 million people and kills about 30,000 people around the world every year. Fri, 20 Dec 2024 15:35:05 EST https://www.sciencedaily.com/releases/2024/12/241220153505.htm https://www.sciencedaily.com/releases/2024/12/241203153925.htm An analysis of fungi collected from peat bogs has identified several species that produce substances toxic to the bacterium that causes the human disease tuberculosis. The findings suggest that one promising direction for development of better treatments might be to target biological processes in the bacterium that help maintain levels of compounds known as thiols. Tue, 03 Dec 2024 15:39:25 EST https://www.sciencedaily.com/releases/2024/12/241203153925.htm https://www.sciencedaily.com/releases/2024/11/241127004159.htm In patients with long COVID, lower pulmonary gas exchange may be associated with impaired cognitive function, according to a new study. Wed, 27 Nov 2024 00:41:59 EST https://www.sciencedaily.com/releases/2024/11/241127004159.htm https://www.sciencedaily.com/releases/2024/11/241116195642.htm To stem the surging antibiotic resistance public health crisis, scientists seek solutions inside the mechanics of bacterial infection. A new study has found a vulnerability related to magnesium availability. This limitation potentially could be exploited to stop the spread of antibiotic resistance. Sat, 16 Nov 2024 19:56:42 EST https://www.sciencedaily.com/releases/2024/11/241116195642.htm https://www.sciencedaily.com/releases/2024/11/241113193029.htm A new study has found highly vulnerable weakness in drug-resistant Mycobacterium tuberculosis, offering a new way to kill them. Wed, 13 Nov 2024 19:30:29 EST https://www.sciencedaily.com/releases/2024/11/241113193029.htm https://www.sciencedaily.com/releases/2024/11/241113192807.htm A new study uncovers vulnerabilities in drug-resistant TB, offering hope for improved treatments. Wed, 13 Nov 2024 19:28:07 EST https://www.sciencedaily.com/releases/2024/11/241113192807.htm https://www.sciencedaily.com/releases/2024/10/241025122422.htm Researchers have identified a novel type of immune cell, called the stem-like CD4 T cell, that plays a pivotal role in anti-tumor immunity. The pre-clinical findings highlight the potential to activate these cells to fight tumors more effectively, offering new hope for broader treatment success, particularly in patients with cancer that is unresponsive to current immunotherapies. Fri, 25 Oct 2024 12:24:22 EDT https://www.sciencedaily.com/releases/2024/10/241025122422.htm https://www.sciencedaily.com/releases/2024/10/241024130754.htm A new study reveals widespread resistance of a major bacterial pathogen to the active ingredients in cleaning agents commonly used in hospitals and homes. Thu, 24 Oct 2024 13:07:54 EDT https://www.sciencedaily.com/releases/2024/10/241024130754.htm https://www.sciencedaily.com/releases/2024/10/241021123143.htm Scientists have discovered that tuberculosis disrupts glucose metabolism in the body. Mon, 21 Oct 2024 12:31:43 EDT https://www.sciencedaily.com/releases/2024/10/241021123143.htm https://www.sciencedaily.com/releases/2024/10/241003123257.htm A new study identified that a semi-synthetic compound can be derived from natural compounds and shows potent activity against tuberculosis (TB), including multi-drug resistant TB. Thu, 03 Oct 2024 12:32:57 EDT https://www.sciencedaily.com/releases/2024/10/241003123257.htm https://www.sciencedaily.com/releases/2024/10/241002165619.htm A compound found in African wormwood -- a plant used medicinally for thousands of years to treat many types of illness -- could be effective against tuberculosis, according to a new study. Wed, 02 Oct 2024 16:56:19 EDT https://www.sciencedaily.com/releases/2024/10/241002165619.htm https://www.sciencedaily.com/releases/2024/09/240920160803.htm Fever temperatures rev up immune cell metabolism, proliferation and activity, but they also -- in a particular subset of T cells -- cause mitochondrial stress, DNA damage and cell death, researchers have discovered. The findings offer a mechanistic understanding for how cells respond to heat and could explain how chronic inflammation contributes to the development of cancer. Fri, 20 Sep 2024 16:08:03 EDT https://www.sciencedaily.com/releases/2024/09/240920160803.htm https://www.sciencedaily.com/releases/2024/09/240920112552.htm A new study highlights the role of natural killer T cells in influencing the immune response to dengue virus, potentially reducing the severity of subsequent infections. Fri, 20 Sep 2024 11:25:52 EDT https://www.sciencedaily.com/releases/2024/09/240920112552.htm https://www.sciencedaily.com/releases/2024/08/240829140836.htm The surprising discovery of a bacterium in a marine sponge from the Great Barrier Reef with striking similarity to Mycobacterium tuberculosis, the pathogen responsible for tuberculosis (TB), could unlock and inform future TB research and treatment strategies. Thu, 29 Aug 2024 14:08:36 EDT https://www.sciencedaily.com/releases/2024/08/240829140836.htm https://www.sciencedaily.com/releases/2024/08/240801121917.htm Highly localized TB strains are less infectious in cosmopolitan cities and more likely to infect people from the geographic area that is the strain's natural habitat. The research provides the first controlled evidence that TB strains may evolve with their human hosts, adapting to be more infectious to specific populations. The findings offer new clues for tailoring preventive treatments after exposure to TB based on affinity between strains host populations. Thu, 01 Aug 2024 12:19:17 EDT https://www.sciencedaily.com/releases/2024/08/240801121917.htm https://www.sciencedaily.com/releases/2024/07/240729110257.htm A study opens new perspectives to better understand how the molecular mechanisms involved in regenerative medicine work. The study focuses on tumor necrosis factor- (TNF- ) and its receptors TNFR, molecules of key interest in biomedicine due to their involvement in multiple diseases such as obesity related to type 2 diabetes mellitus, inflammatory bowel disease and several types of cancer. Mon, 29 Jul 2024 11:02:57 EDT https://www.sciencedaily.com/releases/2024/07/240729110257.htm https://www.sciencedaily.com/releases/2024/07/240722155021.htm Scientists have identified a critical factor that may contribute to the spread of hospital-acquired infections (HAIs), shedding light on why these infections are so difficult to combat. Their study reveals that the dangerous multidrug resistant (MDR) pathogen, Klebsiella, thrives under nutrient-deprived polymicrobial community conditions found in hospital environments. Mon, 22 Jul 2024 15:50:21 EDT https://www.sciencedaily.com/releases/2024/07/240722155021.htm https://www.sciencedaily.com/releases/2024/07/240717162410.htm Cobras kill thousands of people a year worldwide and current antivenom treatment is expensive and does not effectively treat the necrosis of the flesh where the bite occurs. Using CRISPR technology, scientists have discovered a commonly available drug can stop the necrosis, potentially saving thousands of lives a year. Wed, 17 Jul 2024 16:24:10 EDT https://www.sciencedaily.com/releases/2024/07/240717162410.htm https://www.sciencedaily.com/releases/2024/07/240711111542.htm Researchers have revealed a novel association between chromosome 18q deletion syndrome and late-onset combined immunodeficiency (LOCID). Their finding challenges the previously held notion that 18q deletion syndrome only involves humoral immunodeficiency affecting B cells and antibody production. Moreover, the study highlights the need for regular immune function testing in 18q deletion syndrome patients for early diagnosis and improved management. Thu, 11 Jul 2024 11:15:42 EDT https://www.sciencedaily.com/releases/2024/07/240711111542.htm https://www.sciencedaily.com/releases/2024/06/240619143640.htm Tuberculosis is a serious health threat, and the efficacy of the BCG vaccine against tuberculosis diminishes in adulthood, making booster vaccines a realistic option. Mycobacterial DNA-binding protein 1 (MDP1), a protein found in Mycobacterium tuberculosis, elicits higher protective IFN-gamma responses in individuals who suppress tuberculosis, thus making it a vaccine candidate. Wed, 19 Jun 2024 14:36:40 EDT https://www.sciencedaily.com/releases/2024/06/240619143640.htm https://www.sciencedaily.com/releases/2024/06/240614141913.htm Scientists have shown in laboratory experiments that an increase in temperature from 37 to 40 degrees Celsius increased the resistance rate for two antimicrobials, while for a third antimicrobial, the higher temperature reduced the resistance rate. If these results can be replicated in human patients, fever control could be a new way to mitigate the emergence of antibiotic resistance. Fri, 14 Jun 2024 14:19:13 EDT https://www.sciencedaily.com/releases/2024/06/240614141913.htm https://www.sciencedaily.com/releases/2024/06/240605162456.htm A new study suggests that adding common bone loss drugs to azoles can improve efficacy when treating fungal infections. Wed, 05 Jun 2024 16:24:56 EDT https://www.sciencedaily.com/releases/2024/06/240605162456.htm https://www.sciencedaily.com/releases/2024/05/240531122524.htm Scientists have discovered that the most widely-used class of antifungals in the world cause pathogens to self-destruct. The research could help improve ways to protect food security and human lives. Fri, 31 May 2024 12:25:24 EDT https://www.sciencedaily.com/releases/2024/05/240531122524.htm